Cargando…
Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022
Pharmacological management of airway obstructive diseases is a fast-evolving field. Several advances in unravelling disease mechanisms as well as intracellular and molecular pathways of drug action have been accomplished. While the clinical translation and implementation of in vitro results to the b...
Autores principales: | Stolz, Daiana, Matera, Maria Gabriella, Rogliani, Paola, van den Berge, Maarten, Papakonstantinou, Eleni, Gosens, Reinoud, Singh, Dave, Hanania, Nicola, Cazzola, Mario, Maitland-van der Zee, Anke-Hilse, Fregonese, Laura, Mathioudakis, Alexander G., Vestbo, Jørgen, Rukhadze, Maia, Page, Clive P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292790/ https://www.ncbi.nlm.nih.gov/pubmed/37377851 http://dx.doi.org/10.1183/20734735.0267-2022 |
Ejemplares similares
-
Pharmacological treatment and current controversies in COPD
por: Cazzola, Mario, et al.
Publicado: (2019) -
α(1)-Antitrypsin deficiency and chronic respiratory disorders
por: Cazzola, Mario, et al.
Publicado: (2020) -
Novel Anti-Inflammatory Approaches to COPD
por: Cazzola, Mario, et al.
Publicado: (2023) -
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
por: Cazzola, Mario, et al.
Publicado: (2020) -
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)